For the first time in decades, people looking to manage their weight have a genuinely new kind of option. On April 1, 2026, the U.S. Food and Drug Administration approved Foundayo (orforglipron), an oral once-daily pill in the GLP-1 class — and the first of its kind that can be taken at any time of … Continue reading Foundayo (Orforglipron): What to Know About This New GLP-1 Weight Loss Pill